Samir N Khleif

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Induced Apoptosis

Regulatory T Cells

Endoplasmic Reticulum Stress

Top Venues

Nature immunology

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Rahul Nandre, Vivek Verma, Pankaj Gaur, Veerupaxagouda Patil, Xingdong Yang, Zainab Ramlaoui, Nour Shobaki, Mads Hald Andersen, Ayako Wakatsuki Pedersen, Mai-Britt Zocca, Mikayel Mkrtichyan, Seema Gupta, Samir N Khleif
IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status. Cancer immunology research 10 (5) (2022)
Vivek Verma, Nazli Jafarzadeh, Shannon K Boi, Subhadip Kundu, Zhinuo Jiang, Yiping Fan, Jose Lopez, Rahul Nandre, Peng Zeng, Fatmah Alolaqi, Shamim Ahmad, Pankaj Gaur, Simon T Barry, Viia E Valge-Archer, Paul D Smith, Jacques F Banchereau, Mikayel Mkrtichyan, Benjamin A Youngblood, Paulo C Rodriguez, Seema Gupta, Samir N Khleif
MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects. Nature immunology 22 (1) (2020)
Vivek Verma, Rajeev K Shrimali, Shamim Ahmad, Winjie Dai, Hua Wang, Sumin Lu, Rahul Nandre, Pankaj Gaur, Jose Lopez, Moshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, Keith T Flaherty, Jennifer A Wargo, Genevieve M Boland, Ryan J Sullivan, Gad A Getz, Scott A Hammond, Ming Tan, Jingjing Qi, Phillip Wong, Taha Merghoub, Jedd D Wolchok, Nir Hacohen, John E Janik, Mikayel Mkrtichyan, Seema Gupta, Samir N Khleif
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance. Nature immunology 20 (9) (2019)